Search Results

Disclosure Ref 2024239 - FOI Handling data .pdf

Freedom of Information disclosure reference 2024239 relating to number of FOI requests in 2023, those answered within the time limit & system tools used

HRP19 Management of Change Manager's Guide - Appendix 8 Outcome of Consultation - Changes Letter.docx

Disclosure Ref 2024245 - Collabrative working with pharmaceutical companies.pdf

Freedom of information disclosure relating to collaborative working with pharmaceutical companies

Your Health Records Leaflet - updated Jan 2019.pdf

Domestic Abuse and Sexual Violence Policy (P90)

To provide information about the practical help and support that is available to employees of DCHSFT who are currently experiencing domestic abuse, or are experiencing trauma as a result of their past experiences of abuse. This Policy also covers the approach to be taken where an employee’s behaviour towards their family may constitute domestic abuse. Providing this information empowers Managers to take effective, supportive action and reinforces the message that domestic abuse and sexual violence cannot be ignored.

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

L145 - Important advice for casts on lower limbs

Important advice for casts on lower limbs, patient information leaflet.

CoG - 11 March 2020 - updated.pdf

CoG Meeting Pack March 2020

Employee online user guide - temporary staffing.pdf

Disclosure Ref 202243 - Agency for Biomedical SciencePathology - Copy.pdf